Anti-Cardiolipin and Anti-Neutrophil Cytoplasmic Antibodies in Iranian Patients with Behcet's Disease
(ندگان)پدیدآور
Ataollahi, Mohammad RezaAflaki, ElhamNazarinia, Mohammad AliShenavandeh, SaeedehHabibagahi, ZahraGharesi-Fard, BehrouzKamali-Sarvestani, Eskandar
نوع مدرک
TextOriginal Article
زبان مدرک
Englishچکیده
Background: The prevalence of anti-Neutrophil Cytoplasmic Antibodies (ANCAs) and anti-Cardiolipin Antibodies (anti-CL Ab) in Behcet's Disease (BD) and also their roles in vascular involvement is controversial. Objective: To assess the prevalence of ANCAs and anti-CL Ab as well as their correlations with clinical manifestations in Iranian patients with BD. Methods: In this case/control study, the sera from 88 patients with BD and 88 healthy controls were evaluated. The levels of ANCAs and anti-CL Ab were measured using indirect ELISA method. Results: The levels of anti-CL, anti-PR3 and anti-MPO (Myeloperoxidase) IgG autoantibodies between BD patients and healthy controls were not statistically different (p=0.21, p=0.28 and p=0.74, respectively). In addition, there were no significant deferences between BD patients with and without vascular involvement in the levels of anti-CL (1.42 ± 1.24 GPLU/ml and 1.58 ± 1.18 GPLU/ml, respectively; p=0.71), anti-PR3 (0.0 ± 0.0 U/ml and 0.08 ± 0.27 U/ml, respectively; p=0.10) and anti MPO (0.48 ± 0.23 U/ml and 0.52 ± 0.22 U/ml, respectively; p=0.41) IgG autoantibodies. Nevertheless, mean titer of anti-CL IgG was higher in male patients with skin rash than those without skin rash (2.2 ± 0.88 GPLU/ml and 1.11 ± 1.22 GPLU/ml, respectively; p=0.017). Conclusion: While anti-CL, anti- PR3 and anti-MPO IgG autoantibodies do not play a major role in susceptibility to BD or pathogenesis of vascular involvement in our patients, anti-CL Ab might be involved in skin lesion development in Iranian male BD patients. However, the results should be confirmed in other studies.
کلید واژگان
ANCAAnticardiolipin antibody
Behcet’s Disease
شماره نشریه
4تاریخ نشر
2012-12-011391-09-11
ناشر
Shiraz Institute for Cancer Researchسازمان پدید آورنده
Depatrment of ImmunologyDepartment of Rheumatology
Department of Rheumatology
Department of Rheumatology
Department of Rheumatology
Depatrment of Immunology
Depatrment of Immunology
شاپا
1735-13831735-367X



